Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119184594 | 11918459 | 4 | F | 201601 | 20160818 | 20160115 | 20160831 | PER | US-ASTRAZENECA-2015SF18865 | ASTRAZENECA | 866.00 | MON | M | Y | 56.70000 | KG | 20160831 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119184594 | 11918459 | 1 | PS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 1146241 | 202450 | 400 | UG | INHALATION POWDER | QD | ||||||
| 119184594 | 11918459 | 2 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 1146241 | 202450 | 400 | UG | INHALATION POWDER | BID | ||||||
| 119184594 | 11918459 | 3 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 2.5 | MG | QD | ||||||||
| 119184594 | 11918459 | 4 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | AS REQUIRED | 0 | ||||||||||
| 119184594 | 11918459 | 5 | C | ALEVE | NAPROXEN SODIUM | 1 | Oral | AS REQUIRED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119184594 | 11918459 | 1 | Chronic obstructive pulmonary disease |
| 119184594 | 11918459 | 2 | Chronic obstructive pulmonary disease |
| 119184594 | 11918459 | 3 | Hypertension |
| 119184594 | 11918459 | 4 | Chronic obstructive pulmonary disease |
| 119184594 | 11918459 | 5 | Musculoskeletal pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119184594 | 11918459 | Dizziness | |
| 119184594 | 11918459 | Drug dose omission | |
| 119184594 | 11918459 | Dysphonia | |
| 119184594 | 11918459 | Intentional product misuse | |
| 119184594 | 11918459 | Nasopharyngitis | |
| 119184594 | 11918459 | Oropharyngeal pain | |
| 119184594 | 11918459 | Product quality issue | |
| 119184594 | 11918459 | Rhinorrhoea | |
| 119184594 | 11918459 | Urinary tract disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119184594 | 11918459 | 1 | 201509 | 0 |